February 12, 2014
The Japanese Circulation Society (JCS) recently announced the first revision of its guidelines for the pharmacotherapy of atrial fibrillation since 2008. Among other things, the revised guidelines clarify the role of novel oral anticoagulants (NOACs) in patients with atrial fibrillation...read more